Piper Sandler lowered the firm’s price target on Sleep Number (SNBR) to $5 from $12 and keeps a Neutral rating on the shares despite a Q4 revenue and EBITDA beat. While the company appears to be making progress with marketing spend and new product launches, this hasn’t translated to an improvement in sales at this point, the firm argues.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNBR: